期刊文献+

双功能抗体介导胃癌杀伤效应的研究 被引量:2

Bispecific McAb mediated multiple tumor cytotoxicity in gastric cancer
原文传递
导出
摘要 目的 以化学方法将抗CD3 及抗三硝基苯 (TNP)的单克隆抗体 (McAb)交联为双功能抗体。利用此双功能抗体介导人外周血淋巴细胞 (PBLS)对于不同抗胃癌McAb所针对的胃癌细胞进行体内外杀伤试验。方法 利用化学交联法制备双功能抗体 ,以酶联免疫吸附试验 (ELISA)测定McAbs活性 ,以ELISA桥联法、琼脂糖免疫双扩散及十二烷基磺酸钠—聚丙烯酰胺凝胶电泳 (SDS PAGE)对于双功能抗体进行鉴定 ,以细胞杀伤试验及肿瘤生长抑制试验检测双功能抗体作用。结果 将抗CD3 及抗TNPMcAb交联为双功能抗体 ,此双功能抗体可介导PBLS对于不同抗胃癌McAb所针对的胃癌细胞进行体内外杀伤试验。结论 此双功能抗体在肿瘤生物免疫治疗中具有应用前景。 Objective McAb against CD 3 and McAb against TNP were combined into bispecific McAb by chemical methods. With this bispecific McAb, human peripheral blood lymphocytes (PBLS) were introduced to in vitro and in vivo cytotoxic test of any tumor cells by different TNP McAb against gastic cancer. Methods The activity of bispecific McAb prepared by chemical method, was detected by enzyme linked immunosorbent assay (ELISA). The bispecific McAb was identified by bridge ELISA、 Ouchterlony test and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE). Cytotoxic test of tumor cells in vitro and tumor growth inhibition test in vivo were performed for the bispecific McAb function. Results Anti CD 3 and Anti TNP McAbs were successfully combined into bispecific McAb which could conjugate any TNP McAb against gastic cancer and induce PBLS to cytotoxic test of gastric cancer cells in vitro and in vivo. Conclusion The bispecific McAb may very will be useful in the immuno biotherapy of tumors.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2001年第4期285-288,共4页 Chinese Journal of Oncology
基金 北京市自然科学基金资助项目(7932002)
关键词 胃肿瘤 双功能抗体 淋巴细胞 三硝基苯 Gastric neoplasms Bispecific antibody Lymphocytes Trinitrobenzene
  • 相关文献

参考文献1

二级参考文献5

共引文献7

同被引文献20

  • 1王力民,万文徽,陆良军,董志伟.介导多种胃癌杀伤效应的双功能抗体[J].中华肿瘤杂志,1994,16(2):83-87. 被引量:8
  • 2高瀛岱,熊冬生,杨铭,许元富,邵晓枫,彭晖,范冬梅,杨纯正.微型双功能抗体介导人T细胞杀伤耐药实体瘤细胞[J].中华肿瘤杂志,2005,27(11):653-656. 被引量:3
  • 3van Spriel AB, van Ojik HH, van De Winkel JG. Immuno-therapeutic perspective for bispecific antibodies.Immunol Today, 2000, 21: 391-397.
  • 4Drcier T, Baeuerle PA, Fichtner I, et al. T cell costimulus-independent and very efficacious inhibition of tumor growth in mice bearing subcutaneous or leukemic human B cell lymphoma xenografts by a CD19-/CD3-bispecific single-chain antibody construct. J Immunol, 2003, 170:4397-4402.
  • 5Gruen M, Bommert K, Bargou RC. T-cell-mediated lysis of B cells induced by a CD19 × CD3 bispecific single-chain antibody is perforin dependent and death receptor independent. Cancer Immunol lmmunother, 2004, 53:625-632.
  • 6Honemann D, Kuffer P, Rimpler MM, et al. A novel recombinant bispecific single-chain antibody, bscWue-1 × CD3, induces T-cell-mediated cytotoxicity towards human multiple myeloma cells. Leukemia, 2004, 18:636-644.
  • 7Fang M, Zhao R, Yang Z, et al. Characterization of an anti-human ovarian carcinoma x anti-human CD3 bispecific single-chain antibody with an albumin-original interlinker. Gynecol Oncol, 2004, 92:135-146.
  • 8Sharma VK, Bologa RM, Li B, et al. Molecular executors of cell death-differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. Transplantation, 1996, 62:1860-1866.
  • 9Lipman ML, Stevens AC, Bleackley RC,et al. The strong correlation of cytotoxic T lymphocyte-specific serine protease gene transcripts with renal allograft rejection. Transplantation, 1992, 53:73-79.
  • 10Cochlovius B, Kipriyanov SM, Stassar MJ, et al. Cure of Burkitt's lymphoma in severe combined immunodeficiency mice by T cells, tetravalent CD3 × CD19 tandem diabody, and CD28 eostimulation. Cancer Res, 2000, 60:4336-4341.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部